Advertisement

Loading...

Sirnaomics Ltd.

2257.HKHKSE
Healthcare
Biotechnology
HK$6.59
HK$0.59(9.83%)
Hong Kong Market is Open • 13:18

Sirnaomics Ltd. Fundamental Analysis

Sirnaomics Ltd. (2257.HK) shows moderate financial fundamentals with a PE ratio of -5.37, profit margin of -178.07%, and ROE of 1.92%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 3.48%.

Key Strengths

PEG Ratio-3.58

Areas of Concern

ROE1.92%
Operating Margin-188.71%
Cash Position2.23%
Current Ratio0.40
We analyze 2257.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -13300.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-13300.2/100

We analyze 2257.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

2257.HK struggles to generate sufficient returns from assets.

ROA > 10%
-70.01%

Valuation Score

Excellent

2257.HK trades at attractive valuation levels.

PE < 25
-5.37
PEG Ratio < 2
-3.58

Growth Score

Moderate

2257.HK shows steady but slowing expansion.

Revenue Growth > 5%
3.48%
EPS Growth > 10%
35.92%

Financial Health Score

Moderate

2257.HK shows balanced financial health with some risks.

Debt/Equity < 1
-0.94
Current Ratio > 1
0.40

Profitability Score

Weak

2257.HK struggles to sustain strong margins.

ROE > 15%
191.92%
Net Margin ≥ 15%
-178.07%
Positive Free Cash Flow
No

Key Financial Metrics

Is 2257.HK Expensive or Cheap?

P/E Ratio

2257.HK trades at -5.37 times earnings. This suggests potential undervaluation.

-5.37

PEG Ratio

When adjusting for growth, 2257.HK's PEG of -3.58 indicates potential undervaluation.

-3.58

Price to Book

The market values Sirnaomics Ltd. at -7.82 times its book value. This may indicate undervaluation.

-7.82

EV/EBITDA

Enterprise value stands at -6.87 times EBITDA. This is generally considered low.

-6.87

How Well Does 2257.HK Make Money?

Net Profit Margin

For every $100 in sales, Sirnaomics Ltd. keeps $-178.07 as profit after all expenses.

-178.07%

Operating Margin

Core operations generate -188.71 in profit for every $100 in revenue, before interest and taxes.

-188.71%

ROE

Management delivers $1.92 in profit for every $100 of shareholder equity.

1.92%

ROA

Sirnaomics Ltd. generates $-70.01 in profit for every $100 in assets, demonstrating efficient asset deployment.

-70.01%

Following the Money - Real Cash Generation

Operating Cash Flow

Sirnaomics Ltd. generates limited operating cash flow of $-10.64M, signaling weaker underlying cash strength.

$-10.64M

Free Cash Flow

Sirnaomics Ltd. generates weak or negative free cash flow of $-10.64M, restricting financial flexibility.

$-10.64M

FCF Per Share

Each share generates $-0.10 in free cash annually.

$-0.10

FCF Yield

2257.HK converts -10.39% of its market value into free cash.

-10.39%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.37

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-3.58

vs 25 benchmark

P/B Ratio

Price to book value ratio

-7.82

vs 25 benchmark

P/S Ratio

Price to sales ratio

1099.54

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.94

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.40

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.92

vs 25 benchmark

ROA

Return on assets percentage

-0.70

vs 25 benchmark

ROCE

Return on capital employed

0.87

vs 25 benchmark

How 2257.HK Stacks Against Its Sector Peers

Metric2257.HK ValueSector AveragePerformance
P/E Ratio-5.3728.31 Better (Cheaper)
ROE191.92%699.00% Weak
Net Margin-17806.58%-130884.00% (disorted) Weak
Debt/Equity-0.940.34 Strong (Low Leverage)
Current Ratio0.402775.16 Weak Liquidity
ROA-70.01%-14469.00% (disorted) Weak

2257.HK outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sirnaomics Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

2196.83%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-256.58%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-55.71%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ